Spech H J, Liehr H, Mitschke H
Z Gastroenterol. 1983 Nov;21(11):651-9.
Non-alcoholic steatosis hepatitis and fatty cirrhosis represents an unfamiliar liver disease of yet unknown etiology, which is usually indistinguishable from alcoholic lesions by histological criteria. For the affected patients this means automatically the inappropriate assumption of hidden alcohol abuse. Out of 1467 liver biopsies during 1979 to 1982 we selected 25 patients (group I), who either denied alcohol intake or reported negligible consumption. None of them had taken steatogenous drugs or had been treated by jejuno-ileal bypass operation for morbid obesity. Nevertheless, in all cases liver biopsy demonstrated changes that were thought to be characteristic of alcoholic liver disease. This group was compared with an additional series of 25 patients (group II, selected out of 342 alcoholics), who admitted to a mean daily alcohol ingestion of 145 +/- 37 g. According to body weight, sex ratio, estimated degree of hepatocellular fat deposition and relation of steatosis hepatitis (n = 15) to fatty cirrhosis (n = 12) there were no differences between both groups. In contrast to the alcoholics (group II) significantly lower (p less than 0.001) values of serum gamma-glutamyltransferase (127 +/- 138 vs 669 +/- 588 U/l) and mean corpuscular erythrocyte volume (89 +/- 4,7 vs 102 +/- 7,8 fl) occurred among the abstinent patients (group I). However, the considerable overlap of measured values argued against a sufficiently discriminative function of both parameters. On the other hand, the serum SGOT/SGPT ratio (I: 1,0 +/- 0,4 vs II: 3,5 +/- 1,4) as well as the serum immunoglobulin-index IgG/IgA (I: 5,6 +/- 2,1 vs II: 2,7 +/- 0,7) allowed a more than 90% separation between the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)
非酒精性脂肪性肝炎和脂肪性肝硬化是一种病因不明的罕见肝脏疾病,通常在组织学标准上与酒精性病变难以区分。对于受影响的患者来说,这意味着会自动被不恰当地假定存在隐性酒精滥用。在1979年至1982年期间的1467例肝活检中,我们挑选出25例患者(第一组),他们要么否认饮酒,要么报告饮酒量可忽略不计。他们中没有人服用过致脂肪性药物,也没有因病态肥胖接受过空肠回肠旁路手术治疗。然而,所有病例的肝活检均显示出被认为是酒精性肝病特征性的变化。将这组患者与另外25例患者(第二组,从342例酗酒者中选出)进行比较,第二组患者平均每日酒精摄入量为145±37克。根据体重、性别比例、估计的肝细胞脂肪沉积程度以及脂肪性肝炎(n = 15)与脂肪性肝硬化(n = 12)的关系,两组之间没有差异。与酗酒者(第二组)相比,戒酒患者(第一组)的血清γ-谷氨酰转移酶值(127±138对669±588 U/L)和平均红细胞体积(89±4.7对102±7.8 fl)显著更低(p < 0.001)。然而,测量值的大量重叠表明这两个参数的鉴别功能不足。另一方面,血清谷草转氨酶/谷丙转氨酶比值(第一组:1.0±0.4对第二组:3.5±1.4)以及血清免疫球蛋白指数IgG/IgA(第一组:5.6±2.1对第二组:2.7±0.7)使得两组之间的分离度超过90%。(摘要截取自250字)